Statement

on

B Sample Test Update From AJ Allmendinger
July 24, 2012
Statement from Tara Ragan, Vice President, Walldinger Racing Inc.

Charlotte, NC (July 24, 2012)-

Aegis Analytical Laboratories in Nashville has delivered the results of the “B” sample test for Penske Racing driver AJ Allmendinger, which confirmed the results of the “A” test.

“This was not the news we wanted to hear and we will work to get to the source of what may have caused this. To that end, we have secured the services of an independent lab to conduct thorough testing on every product within AJ’s home and motor coach to find what might collaborate with his test, which created results that were within nanograms of accepted standards.

We are working closely with NASCAR and Penske Racing to identify the next action steps in this process. We continue to be extremely grateful by the breadth and scope of support for AJ from his fans and partners. We would like to again thank NASCAR, Penske Racing and all our sponsor partners for the open communication, and for helping us at every step in this process. We expect to have further updates in the upcoming days.”

-Tara Ragan, Vice President, Walldinger Racing Inc.

on

SHELL AND PENNZOIL STATEMENT:

Shell and Pennzoil believe that the process and procedures that NASCAR has in place as part of their substance abuse policy are appropriate and serve to ensure that the sport and its participants are held to the highest standards.

We share Penske Racing’s disappointment with the result of AJ’s (Allmendinger) B sample test and will work closely with them to determine plans moving forward. We hope for the best for AJ during this difficult time.

on

PENSKE RACING STATEMENT:

In accordance with NASCAR’s Substance Abuse Policy, Penske Racing was notified today of AJ Allmendinger’s positive B sample test. We respect NASCAR’s policy and the process they have taken with this matter.

Penske Racing is very disappointed with the result of the B sample test and will evaluate its course of action as it pertains to AJ over the coming week.

Sam Hornish Jr., will drive the No. 22 Dodge Charger this weekend at Indianapolis and next weekend at Pocono.

on

“I have informed NASCAR that I have requested that the ‘B’ sample be tested, following the steps according to NASCAR’s 2012 rule book regarding this situation. I fully respect NASCAR’s drug usage policy and the reasons they have it.

I am hoping this can get resolved as quickly as possible so that I can get back to driving the No. 22 Penske Racing Dodge. I am sorry that this has caused such a distraction for my Penske Racing team, our sponsors and fans.

Obviously I would never do anything to jeopardize my opportunity here at Penske Racing or to my fellow drivers. I am very conscious about my training and health and would never knowingly take a prohibited drug.”

on

Eric McClure, driver of the No. 14 Hefty®/Reynolds Wrap® Toyota, is stable and alert following a late-race incident yesterday (Saturday) during the NASCAR Nationwide Series event at Talladega Superspeedway.

He is undergoing tests and remains under observation at the University of Alabama at Birmingham hospital.

McClure and his family would like to express their thanks to the NASCAR community for their thoughts, support and concern.

The team will release any updates as they occur.

SUNDAY EVENING UPDATE
Eric McClure, driver of the No. 14 Hefty®/Reynolds Wrap® Toyota, will remain hospitalized overnight for further observation at UAB Medical Center in Birmingham, Alabama.

The team will release updates as they occur.

CLICK FOR MONDAY EVENING UPDATE